DP Clinical

DP Clinical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

DP Clinical is an established, mid-sized CRO headquartered in Rockville, Maryland, with a strong track record spanning three decades. It offers a full suite of clinical development services, from study design to execution, with particular expertise in complex therapeutic areas like Critical Care, Neuroscience, and Oncology. As a private, service-based company, its success is tied to its deep therapeutic knowledge, flexible service model, and ability to partner with a diverse range of sponsors in the drug development ecosystem.

Critical CareDermatologyInfectious DiseaseNeuroscienceOncologyOphthalmology

Technology Platform

Integrated clinical trial management services and deep therapeutic area expertise, rather than a proprietary technology platform. Relies on operational experience and tailored project management.

Opportunities

Growth in outsourcing by biotech and pharma, especially in complex therapeutic niches like cell/gene therapy and critical care where DP Clinical has deep expertise.
The increasing complexity and cost of clinical trials drive demand for specialized, flexible CRO partners.

Risk Factors

Intense competition from larger global CROs and niche players.
Revenue volatility tied to project-based work and biotech funding cycles.
Operational and reputational risk from any clinical trial setbacks managed on behalf of clients.

Competitive Landscape

Operates in a highly competitive CRO market dominated by large players (IQVIA, PPD, ICON) but competes by offering flexibility and deep specialization in select therapeutic areas to mid-sized and smaller sponsors. Competes with other niche and full-service CROs for client contracts.